Immune exclusion, or the lack of immune cells in the vicinity of cancer cells, predicts poor patient outcomes in multiple cancers, including triple-negative breast cancer (TNBC). Now, researchers have ...
BOSTON--(BUSINESS WIRE)--Parthenon Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today announced ...
Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via promoting M2 macrophages polarization.
Assessment of Leptomeningeal Carcinomatosis Diagnosis and Outcomes from 2005 to 2015 at Ohio State University. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does ...
Redx Pharma plc has described discoidin domain-containing receptor 1 (DDR1) and/or discoidin domain-containing receptor 2 (DDR2) inhibitors reported to be useful for the treatment of cardiovascular, ...
Redx Pharma plc has described henyl- and pyridopyrazole derivatives as discoidin domain-containing receptor DDR1 and/or DDR2 inhibitors. They are reported to be useful for the treatment of fibrosis, ...
CAMBRIDGE, UK. — Dec, 19, 2006 - ARM [(LSE:ARM); (NASDAQ:ARMHY)] today announced the availability of the ARM® Velocityâ„¢ DDR1 and DDR2 (1/2) memory interface in its Artisan® physical IP family to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results